Testing effectiveness (Phase 2)Study completedNCT03786237What this trial is testingRigosertib for RDEB-SCCWho this might be right forEpidermolysis Bullosa DystrophicaSquamous Cell Carcinoma Prof. Johann Bauer 2
Testing effectiveness (Phase 2)Study completedNCT03536143What this trial is testingA Phase I/II Study of KB103, a Topical HSV1-COL7, on DEB PatientsWho this might be right forDystrophic Epidermolysis Bullosa Krystal Biotech, Inc. 12
Not applicableStudy completedNCT00904163What this trial is testingCharacteristics of Adult Patients With Recessive Dystrophic Epidermolysis BullosaWho this might be right forEpidermolysis Bullosa Dystrophica Stanford University 13
Not applicableStudy completedNCT03183934What this trial is testingA Follow-up Study to Evaluate the Efficacy and Safety of ALLO-ASC-DFU in ALLO-ASC-EB-101 Clinical TrialWho this might be right forDystrophic Epidermolysis Bullosa Anterogen Co., Ltd. 2
Not applicableStudy completedNCT04757727What this trial is testingGynecological Follow-up of Patients With Dystrophic Epidermolysis Bullosa (EBD)Who this might be right forDystrophic Epidermolysis Bullosa Centre Hospitalier Universitaire de Nice 27
Testing effectiveness (Phase 2)Ended earlyNCT02090283What this trial is testingOpen-Label Extension Study to Evaluate the Safety of SD-101 Cream in Participants With Epidermolysis BullosaWho this might be right forEpidermolysis Bullosa Scioderm, Inc. 42
Not applicableWithdrawnNCT04213703What this trial is testingA Pilot Study to Explore the Role of Gut Flora in Epidermolysis BullosaWho this might be right forEpidermolysis BullosaEpidermolysis Bullosa SimplexEpidermolysis Bullosa Dystrophica ProgenaBiome
Early research (Phase 1)Study completedNCT03472287What this trial is testingTo Evaluate the Pharmacokinetic of Diacerein and Rhein After Maximum Use in Patients With Epidermolysis Bullosa (EB)Who this might be right forEpidermolysis Bullosa (EB)Epidermolysis Bullosa SimplexDystrophic Epidermolysis Bullosa+1 more Castle Creek Pharmaceuticals, LLC 11
Testing effectiveness (Phase 2)Study completedNCT03529877What this trial is testingAllogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis BullosaWho this might be right forRecessive Dystrophic Epidermolysis Bullosa RHEACELL GmbH & Co. KG 16
Not applicableStudy completedNCT03241628What this trial is testingProof of Concept Study for a Dressing GloveWho this might be right forEpidermolysis Bullosa Dystrophica Guy's and St Thomas' NHS Foundation Trust 14
Not applicableUnknownNCT03269474What this trial is testingComputational Drug Repurposing for All EBS CasesWho this might be right forEpidermolysis BullosaHealthyGenetic Skin Disease+3 more Joyce Teng 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07011589What this trial is testingTargeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART)Who this might be right forEpidermolysis Bullosa (EB)Epidermolysis Bullosa AcquisitaRecessive Dystrophic Epidermolysis Bullosa+1 more M. Peter Marinkovich 18
Very early researchStudy completedNCT05533866What this trial is testingCharacterization of the Microbiome in Colonized Dystrophic and Junctional Epidermolysis Bullosa Wounds Before and After Use of APR-TD011 ® Spray SolutionWho this might be right forEpidermolysis Bullosa Northwestern University 15
Testing effectiveness (Phase 2)Looking for participantsNCT06834035What this trial is testingTargeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis BullosaWho this might be right forEpidermolysis BullosaEpidermolysis Bullosa AcquisitaDystrophic Epidermolysis Bullosa+1 more M. Peter Marinkovich 8
Testing effectiveness (Phase 2)Study completedNCT05143190What this trial is testingExtension Study to PTR-01-002 (A Study in Recessive Dystrophic Epidermolysis Bullosa (RDEB) Patients Previously Treated With PTR-01)Who this might be right forRecessive Dystrophic Epidermolysis Bullosa Phoenix Tissue Repair, Inc. 2
Testing effectiveness (Phase 2)Looking for participantsNCT07193134What this trial is testingGMEB-SASS: A Gene-Modified Skin Substitute for RDEB TreatmentWho this might be right forRDEBRecessive Dystrophic Epidermolysis BullosaEpidermolysis Bullosa Dystrophica, Recessive CHU de Quebec-Universite Laval 9
Testing effectiveness (Phase 2)Study completedNCT01263379What this trial is testingGene Transfer for Recessive Dystrophic Epidermolysis BullosaWho this might be right forEpidermolysis Bullosa DystrophicaEpidermolysis Bullosa Abeona Therapeutics, Inc 12
Testing effectiveness (Phase 2)Study completedNCT02698735What this trial is testingGentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB) Nonsense Mutation PatientsWho this might be right forRecessive Dystrophic Epidermolysis Bullosa University of Southern California 5
Not applicableStudy completedNCT05944250What this trial is testingA Pilot Study to Evaluate a Temporary Skin Substitute (Spincare® Matrix) for Wound Healing in RDEB PatientsWho this might be right forRecessive Dystrophic Epidermolysis Bullosa Stanford University 6
Very early researchStudy completedNCT04177498What this trial is testingRigosertib in Patients With Recessive Dystrophic Epidermolysis Bullosa Associated SCCWho this might be right forRecessive Dystrophic Epidermolysis Bullosa Thomas Jefferson University 3